Rosato lab Publications

Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients
Roch, M, Varela, MC, Taglialegna, A & Rosato, AE 2020, The Journal of antimicrobial chemotherapy, vol. 75, no. 1, pp. 126-134.

Identification and molecular epidemiology of methicillin resistant Staphylococcus pseudintermedius strains isolated from canine clinical samples in Argentina
Gagetti, P, Wattam, AR, Giacoboni, G, De Paulis, A, Bertona, E, Corso, A & Rosato, AE 2019, BMC Veterinary Research, vol. 15, no. 1, 264.

Activity of telavancin against staphylococcus aureus isolates, including those with decreased susceptibility to ceftaroline, from cystic fibrosis patients
Roch, M, Varela, MC, Taglialegna, A, Rose, WE & Rosato, AE 2018, Antimicrobial agents and chemotherapy, vol. 62, no. 9, e00956-18.

Genetic diversity of KPC-producing Escherichia coli, klebsiella oxytoca, serratia marcescens, and citrobacter freundii isolates from Argentina
De Belder, D, Lucero, C, Rapoport, M, Rosato, A, Faccone, D, Petroni, A, Pasteran, F, Albornoz, E, Corso, A & Gomez, SA 2018, Microbial drug resistance (Larchmont, N.Y.), vol. 24, no. 7, pp. 958-965.

Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in staphylococcus aureus
Zheng, X, Berti, AD, McCrone, S, Roch, M, Rosato, AE, Rose, WE & Chen, B 2018, Antimicrobial agents and chemotherapy, vol. 62, no. 2, e02100-17.

Daptomycin resistance in clinical MRSA strains is associated with a high biological fitness cost
Roch, M, Gagetti, P, Davis, J, Ceriana, P, Errecalde, L, Corso, A & Rosato, AE 2017, Frontiers in Microbiology, vol. 8, no. DEC, 2303.

Molecular bases determining daptomycin resistance-mediated resensitization to ß-lactams (seesaw effect) in methicillin-resistant Staphylococcus aureus
Renzoni, A, Kelley, WL, Rosato, RR, Martinez, MP, Roch, M, Fatouraei, M, Haeusser, DP, Margolin, W, Fenn, S, Turner, RD, Foster, SJ & Rosato, AE 2017, Antimicrobial agents and chemotherapy, vol. 61, no. 1, e01634-16.

Modeling meropenem treatment, alone and in combination with daptomycin, for KPC-producing Klebsiella pneumoniae strains with unusually low carbapenem MICs
Gagetti, P, Pasteran, F, Martinez, MP, Fatouraei, M, Gu, J, Fernandez, R, Paz, L, Rose, WE, Corso, A & Rosato, AE 2016, Antimicrobial agents and chemotherapy, vol. 60, no. 8, pp. 5047-5050.

The staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A
Jousselin, A, Manzano, C, Biette, A, Reed, P, Pinho, MG, Rosato, AE, Kelley, WL & Renzoni, A 2016, Antimicrobial agents and chemotherapy, vol. 60, no. 3, pp. 1656-1666.

Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus
Costa, SS, Viveiros, M, Rosato, AE, Melo-Cristino, J & Couto, I 2015, BMC microbiology, vol. 15.

Iron- and hemin-dependent gene expression of Porphyromonas gingivalis
Anaya-Bergman, C, Rosato, AE & Lewis, JP 2015, Molecular Oral Microbiology, vol. 30, no. 1, pp. 39-61.

PBP2a mutations causing high-level ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates
Long, SW, Olsen, RJ, Mehta, SC, Palzkill, T, Cernoch, PL, Perez, KK, Musick, WL, Rosato, AE & Musser, JM 2014, Antimicrobial agents and chemotherapy, vol. 58, no. 11, pp. 6668-6674.

Staphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic ß-lactam resistance modifiers
Palacios, L, Rosado, H, Micol, V, Rosato, AE, Bernal, P, Arroyo, R, Grounds, H, Anderson, JC, Stabler, RA & Taylor, PW 2014, PloS one, vol. 9, no. 4, e93830.

Identification of point mutations in clinical staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione
Dean, MA, Olsen, RJ, Long, SW, Rosato, AE & Musser, JM 2014, Infection and immunity, vol. 82, no. 4, pp. 1600-1605.

Live Chat Available